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Abstract
Epigenetics refers to stable and long-term alterations of cellular traits that are not caused
by changes in the DNA sequence per se. Rather, covalent modifications of DNA and his-
tones affect gene expression and genome stability via proteins that recognize and act
upon such modifications. Many enzymes that catalyse epigenetic modifications or are
critical for enzymatic complexes have been discovered, and this is encouraging investi-
gators to study the role of these proteins in diverse normal and pathological processes.
Rapidly growing knowledge in the area has resulted in the need for a resource that
compiles, organizes and presents curated information to the researchers in an easily
accessible and user-friendly form. Here we present EpiFactors, a manually curated data-
base providing information about epigenetic regulators, their complexes, targets and
products. EpiFactors contains information on 815 proteins, including 95 histones and
protamines. For 789 of these genes, we include expressions values across several
samples, in particular a collection of 458 human primary cell samples (for approximately
200 cell types, in many cases from three individual donors), covering most mammalian
cell steady states, 255 different cancer cell lines (representing approximately 150 cancer
subtypes) and 134 human postmortem tissues. Expression values were obtained by the
FANTOM5 consortium using Cap Analysis of Gene Expression technique. EpiFactors
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also contains information on 69 protein complexes that are involved in epigenetic regula-
tion. The resource is practical for a wide range of users, including biologists, pharma-
cologists and clinicians.
Database URL: http://epifactors.autosome.ru
Introduction
Epigenetics has emerged as an extremely fast-growing area
of biomedical research. The term ‘epigenetics’ covers DNA
and histone modifications, as well as chromatin remodel-
ing. DNA methylation, one of the key epigenetic mechan-
isms, is involved in differentiation, pluripotency, aging,
memory formation and responses to environmental
changes (1–5), and it is associated with repression of tran-
scription when present in promoters and expression activa-
tion when present in the gene bodies (reviewed, for
example, in Refs. (6,7)). At least three independent DNA
methyltransferases, DNMT1, DNMT3A and DNMT3B,
can establish DNA methylation. The loss of any of these
proteins is lethal in mice (8). How DNA methylation af-
fects transcription is still under debate (9–12). Also, the
mechanisms of active DNA demethylation are not com-
pletely understood. However, several groups of proteins,
such as ten-eleven translocation (TET) proteins and DNA
glycosylases have been shown to be involved (13). Also, at
least two groups of proteins, methyl-binding domain pro-
teins (14) and CxxC proteins (15), can recognize the unme-
thylated or methylated state of DNA and transmit signals
to other regulatory proteins.
Chromatin modification and remodeling are also vital
epigenetic mechanisms. In eukaryotes, the core chromatin
structural unit—the nucleosome—is composed of eight his-
tones (two copies of H2A, H2B, H3 and H4) (16). The
human genome encodes for more than 70 different histone
proteins, expressed differently depending upon the cellular
and environmental conditions. In human sperm most of the
histones are replaced by protamines, which is essential for
the higher DNA condensation in sperm cells (17). Histones
are subject to a large number of reversible post-translational
modifications. Such modifications can modulate chromatin
structure, and they can be recognized by specific proteins or
protein domains. Such modifications are crucial for epigen-
etic regulation of transcription, genome stability, DNA
damage response, X chromosome inactivation and forma-
tion of epigenetic memory (18–21). Various histone marks
tend to co-occur in patterns, usually referred to as the his-
tone code (22), which in turn can be ‘read’ by other proteins
(23). So far dozens of genes are known to encode
proteins that establish or remove histone modifications in
the human genome. Chromatin remodeling is carried out by
ATP-dependent complexes, which either move, eject or re-
structure nucleosomes (24). Histone chaperones, critical for
nucleosome assembly following DNA replication, DNA re-
pair and gene transcription, also play an important role in
epigenetic regulation (25).
The definition of epigenetic factors is not trivial. In add-
ition to the core epigenetic proteins that initiate, modify
and act upon epigenetic modifications as described earlier,
there are a range of borderline cases, in particular because
these core proteins are part of large networks of gene regu-
lation and complex formation (i.e. through protein–protein
interactions). Such borderline cases may include transcrip-
tion factors (TFs) that regulate genes coding for epigenetic
factors, TF-like proteins that recruit epigenetic proteins to
specific genomic regions, micro-RNAs that act upon
mRNAs for epigenetic proteins and long non-coding RNAs
that are involved in genome organization and gene regula-
tion. Genes encoding those regulators can in turn be regu-
lated epigenetically or by specific TFs (26, 27), enormously
expanding the regulatory network with no clear bounda-
ries between epigenetic and non-epigenetic regulation.
Here we mainly focus on the core epigenetic proteins, but
some of the borderline cases also have to be included, in
particular if they are part of protein complexes that are im-
portant for epigenetic processes.
There is an increasing awareness that we have to con-
sider the cell as composed of molecular complexes, each of
which performs an independent, discrete biological func-
tion (28). In line with this, it should be emphasized that in
particular chromatin remodeling is usually not performed
by single protein, but by a protein complex, which serves
to activate its members or increase their stability. Recent
studies of epigenetic complexes have revealed a substantial
diversity of proteins that are involved. Most complexes
that previously were considered unique appeared to be
members of large complex families, as other proteins from
the same family could replace core subunits of the com-
plex. There are several families of well-studied epigenetic
complexes in eukaryotes, such as SWI/SNF, ISWI, NuRD,
INO80 and PcG. To make the picture even more compli-
cated, some proteins can participate in formation of a var-
iety of different complexes.
Over the past decade, tremendous efforts have been dir-
ected towards understanding the epigenetic regulatory
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mechanisms. It is worth noting that deregulation of epigen-
etic processes is observed in many complex human dis-
eases, including cancer, neurodegenerative diseases and
diabetes (29–31). Lately, chromatin-modifying proteins
have been considered as promising drug targets (32).
Therefore, the information about epigenetic regulators and
their complexes is extremely relevant, not only for under-
standing fundamental biological processes but also for
understanding human disorders. This makes a curated and
structured source of such information beneficial not only
for biologists but also for clinicians. Currently, several
publically available databases provide information on the
topic. Below we present a brief overview of them.
Databases on DNA methylation, such as MethDB (33,
34), NGSmethDB (35), MethBank (36), MethylomeDB
(36), MethHC (37), MethyCancer (38) and The Cancer
Genome Atlas (TCGA) (39), primarily provide information
about methylation patterns in various normal and patho-
logical conditions, obtained by different experimental tech-
niques. Yet, detailed information about proteins
establishing DNA methylation or performing active DNA
demethylation, in particular in combination with relevant
expression data in various cells, is missing.
Histones and their modifications in humans (mammals)
are partially addressed in Human Histone Modification
Database (HHMD) (40), Histone Database (41) and
HIstome (42). The HHMD focuses on integration of ex-
perimental data on genomic distributions of histone modi-
fications. Therefore the number of modifications covered
is limited by the number of available antibodies.
Moreover, according to the web site, the last update of the
database was published 3 years ago, which makes the in-
formation somewhat outdated. Histone Database (41) has
an evolutionary focus collecting data on histones in a large
number of organisms including human. Yet, data on his-
tone-modifying enzymes are not integrated. The recently
developed HIstome database (42) compensates for this dis-
advantage and combines information on the histone pro-
teins and the histone-modifying enzymes. However, other
categories of epigenetic regulators are not covered.
Over the last several years, there has been an increased
recognition of the role of chromatin remodelers. As a re-
sult, databases with a broader scope have started to ap-
pear. Those databases incorporate not only information on
histones and histone-modifying enzymes but also include
other proteins affecting the chromatin structure without
direct histone modifications. Among such databases are
ChromDB (43), CREMOFAC (44) and CR Cistrome (45).
ChromDB (43), which provides information on chromatin-
associated proteins for a broad range of organisms, focuses
on extremely well-studied plant genes encoding chromatin
remodelers. CREMOFAC (44) focuses on ATP-dependent
and -independent chromatin-remodeling factors with
reduced information on histone-modifying enzymes. CR
Cistrome (45) contains information about both chromatin
remodelers and histone-modifying enzymes, but with a pri-
mary focus on their interactions based on
experimental data (ChIP-Seq) in human and mouse.
Although these databases represent a significant step to-
ward a comprehensive epigenetic knowledge base, each of
them is still missing some important classes of epigenetic
regulators.
Some databases go one step further and try to integrate
information on various epigenetic regulators. Among them
is PEpiD (46), an epigenetic database that combines the
three extensively characterized epigenetic mechanisms
(DNA methylation, histone modification and microRNA),
implicated in prostate cancer of human, mouse and rat.
Also EPITRANS (47) and TCGA (39) should be men-
tioned, as they integrate epigenome and transcriptome
data. Furthermore, there are several databases that incorp-
orate all sorts of epigenetic information, such as the NCBI
Epigenomics resource (48, 49), NIH Roadmap
Epigenomics Program data resource (50) or ENCODE
(27). Although such resources provide enormous possibil-
ities for exploring epigenomic data sets, they are mainly
focused on the genomic distribution of epigenetic
modifications.
Traditionally, the information about protein inter-
actions is reported in a form of one-to-one interactions
[protein–protein interactions (PPIs)]. There are several
databases providing users with thousands of PPIs, usually
with no distinction between stable (long-time, complex
forming) and transient (short-time, reversible and context-
dependent) interactions. Yet, recently the focus has
changed, and the Complex Portal (51), a complex-based
database of protein interactions is now part of the IntAct
(52) molecular interaction database. Through Complex
Portal protein complexes from model organisms are avail-
able to search, view and download. But although com-
plexes in the database are annotated with details about
their function, the Complex Portal does not focus on epige-
netically related complexes, and therefore information
about such complexes is difficult to extract.
Despite the availability of existing resources on epigen-
etic regulation, there is still a need for a comprehensive
database that provides a compilation of functional infor-
mation about epigenetic regulators and their expression in
multiple cell types. In addition, since the role and diversity
of epigenetic complexes now is recognized, interactions be-
tween epigenetic regulators resulting in formation of stable
epigenetic complexes have to be included. Most import-
antly, comprehensive functional annotation is needed to
cover all possible epigenetic functions. To this end, we
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present EpiFactors; a database encompassing detailed and
curated information about 815 proteins and 69
complexes involved in epigenetic regulation. To the best of
our knowledge, such ample compilation of information on
epigenetic factors is not available in any other public
resources.
Database content and development
To create a complete database of the epigenetic regulators,
a decision has to be made on which genes and proteins to
include. For this purpose we developed a definition of epi-
genetic factors. Such definitions are always arbitrary to
some extent, although we believe that our definition covers
the majority of the genes and proteins involved in epigen-
etic regulation.
EpiFactors definitions
We defined epigenetic factors as
• Proteins acting as histones, histone variants or
protamines;
• Proteins performing post-translational modifications of
histones or recognizing such modifications (histone
modification ‘writers’, ‘erasers’ or ‘readers’);
• Proteins changing the general structure of chromatin
(performing chromatin remodeling), including
• Proteins that move, eject or restructure nucleosomes
(ATP-dependent chromatin remodelers);
• Proteins that incorporate histone variants into the
nucleosomes.
• Proteins assisting histone folding and assembly;
• Proteins acting upon modifications of DNA or RNA in
such a way that it affects gene expression, but not
through RNA processing;
• Protein cofactors forming complexes with epigenetic fac-
tors, where complex formation is important for the
activity.
Epigenetic complexes
As a starting point, we used the UniProt definition of pro-
tein complexes as provided in the ‘function’ field for his-
tone-modifying enzymes and chromatin-remodeling
proteins. Unfortunately, many of the techniques used to
isolate proteins are essentially disruptive to large protein
complexes, and even worse, various popular techniques
are disruptive to a different extent, which leads to a
disagreement between studies with respect to whether
some proteins are stable members of a complex or just
demonstrating transient PPIs. Although we could not fully
overcome this issue, we used information from the most re-
cent papers and expert opinions to exclude transient inter-
actions and to correct the sets of proteins from each
complex accordingly. To specify members of the PCG1
complex family, we used the classification provided by
Gao et al. (53). Some histone-modifying and chromatin-re-
modeling complexes were updated according to
Schuettengruber et al. (54). To improve annotation of all
repressive complexes, we used a comprehensive review by
Laugesen and Helin (55). A complete list of references is
linked to the relevant records of the database.
Recent findings suggest that the borders separating pro-
tein complexes are becoming vague (56), making definition
of the complexes even more complicated. In that line, we
tried to group epigenetic complexes, and therefore the
complexes are structured into 19 functional complex
families.
Data sources
To create EpiFactors we merged the most recent and com-
plete sets of genes related to epigenetics from several sour-
ces, including the Histone Infobase (42) and selected
relevant research papers and reviews (57–60). Data from
text mining using MeSHOP (MeSH Over-representation
Profiles) was also included (W. Wasserman, personal com-
munication). We searched the UniProt database for his-
tones, protamines, their modifying enzymes, DNA
methylation enzymes, and chromatin-remodeling proteins
in ‘reviewed’ entries of UniProt using the keywords ‘his-
tone’, ‘protamine’, ‘chromatin’ and ‘methylation’, with
‘human’ as species. We manually extracted information
about protein complexes from the ‘function’ field of the
histone and DNA-modifying enzymes descriptions, and
then searched for other proteins in such complexes using
the name of the complex as a keyword in the ‘reviewed’
entries of UniProt. We also searched for and investigated
paralogs of all identified proteins. However, only proteins
where the role as an epigenetic factor was supported by lit-
erature were actually included in EpiFactors. We curated
the obtained entries to remove non-specific proteins and
add missing ones based on the literature. Through this ex-
haustive database and literature search we identified 95
histones and histone variants (including protamines), 720
DNA/RNA, histone and chromatin-modifying enzymes
and their cofactors, and 69 epigenetically relevant com-
plexes. Publications have been used to check the informa-
tion on every single protein entry, its function, targets and
products (if applicable), and complexes that a protein
could be involved in. The database provides 598 unique
PubMed references to support the annotation of proteins
and complexes.
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Functional classes annotation
An important aspect of the database is to provide a use-
ful and comprehensive functional annotation of epigen-
etic factors. Such annotation is often implemented by
using standard gene ontology (GO), which has a rich
vocabulary for describing protein function. However,
in this case we wanted a smaller set of terms that is
more directly targeted toward key aspects of
epigenetics. We therefore developed the following annota-
tion scheme.
General layout:
1. Function [optional j terms]
1.1. Modification (alternative j terms)
1.2. Modification
1.3. ...
Terms that may be used:
1. DNA modification [cofactor]
1.1. DNA (methylation j demethylation j hydroxyme-
thylation j . . . )
2. RNA modification [cofactor]
2.1. RNA (phosphorylation j deamination j degradation
j . . . )
2.2. mRNA editing
3. Chromatin remodeling [cofactor]
4. Histone chaperone [cofactor]
5. Histone modification [read j write j erase] [cofactor]
5.1. Histone (methylation j acetylation j phosphoryl-
ation j ubiquitination j sumoylation j GlcNAcylation j
citrullination j . . . )
6. Polycomb group (PcG) protein
7. Scaffold protein
8. TF
8.1. TF (activator j repressor)
We included TFs only if they have been explicitly
shown to have epigenetic function, for example as es-
sential members of histone-modifying complexes.
Target molecules, targets and product annotation
We also annotated entries (proteins and complexes)
with information about targets, if such information was
available. We provided three types of target/product
annotations, covering molecule, target and product.
The molecule may be either chromatin, histone,
DNA, RNA or mRNA. The target corresponds to the par-
ticular nucleotide or amino acid that is affected. For ex-
ample, C for DNA or H3K4 for histone. Product
annotation provides the output of the reaction, as detailed
as possible. This could be, for example, H3K4me or
H3K4me3.
Data processing, integration and links to external
resources
Custom scripts were used to parse UniProt, HGNC,
Entrez, MGI and Pfam databases. In addition to the anno-
tation mentioned earlier, we provide external links to
UniProt, HGNC, Entrez, MGI, Pfam, FANTOM5 SSTAR
(Abugessaisa et al. in preparation), and other public data-
bases. FANTOM5 SSTAR provides a way to explore cell
samples, sites of transcriptional initiation and regulators
analysed in the FANTOM5 project (61). Links to the cor-
responding entry (cell type or gene) of FANTOM5 SSTAR
are available from both genes (via EntrezID) and expres-
sion pages. It is worth noting that some epigenetic factors
are also TFs and therefore can bind DNA in a sequence-
specific manner. If such sequence preferences are known
we provide an external link to a corresponding entry of the
HOCOMOCO database, which contains curated models
of sequence-specific transcriptional factor binding sites
(TFBS) (62).
Information on proteins/genes
The protein page (for each EpiFactor gene or histone) pro-
vides a summary of all available information about the
protein and expression profiles of the corresponding gene
obtained by Cap Analysis of Gene Expression (CAGE), in
particular for 458 human primary cell samples, 255 differ-
ent cancer cell lines and 134 human post-mortem tissues
(61). Expression values are sorted and pre-filtered to have
expression higher than 10 TPM (CAGE tags per million,
relative log expression normalization), but this threshold
can be dynamically adjusted. The quantile rank of the gene
among all EpiFactors in a given sample is also provided.
The information on the gene expression can also be ob-
tained on a per sample basis through the ‘Expression’ tab.
It shows all genes expressed in a particular sample. For
each gene we also provide quantile ranks of the gene ex-
pression in this sample relatively to all other samples.
For the majority of the proteins the respective mouse
ortholog from MGI is provided. Where possible we anno-
tated proteins with functional class/function, complex and
target molecule/product (see categories above). We ex-
tracted such annotation from relevant publications, and
the PubMed ID (PMID) is given in the corresponding field.
Information on complexes
The complex page provides information on important
complexes in epigenetics, including proteins involved in
complex formation, the molecular and specific targets and
products, as well as relevant PMID references supporting
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the information. It is worth noting that essential and vari-
able members of the complex (according to UniProt anno-
tation) are marked in different colors.
Implementation, web interface and visualization
EpiFactors is available online via a user-friendly web inter-
face implemented as a Ruby-on-Rails front-end with an
SQLite back-end. The home page provides a graphical
representation of epigenetic processes with all major elem-
ents being ‘clickable’ and linked to the corresponding com-
plex groups (Figure 1). The content of the database can
also be accessed through four specific tables: ‘Genes’,
‘Complexes’, ‘Histones and protamines’, ‘Expression’, ei-
ther directly or by using keyword search. Each data table
contains a customizable set of columns presenting informa-
tion on respective entities. A user can also browse individ-
ual histones, protamines, epigenetic modifiers and their
Figure 1. Interactive navigation figure for web page. Names of the histones and complexes are linked to the corresponding entities of the database.
Since complexes are represented by a group name, all complexes of the group will be shown when the complex name is clicked on the website navi-
gation figure. Complexes are located in the area corresponding to the shown function. For example CAF-1 (in lower right corner) participates in nu-
cleosome assembly after replication.
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complexes. We also provide some general information in a
‘Docs’ section of the website, to explain the resource struc-
ture and how it can be used.
Downloads
All tables from the EpiFactors database can be down-
loaded in csv format. The downloaded file contains all
rows and columns that are currently visible, as well as cor-
responding external links to facilitate downstream ana-
lysis. For a particular gene, the expression data can also be
downloaded in csv format for all samples where the ex-
pression level of the gene is above a selected threshold.
Also, expression tables of all the epigenetic factors in all
samples can be downloaded from the Download section of
the database.
Summary statistics
The content of the EpiFactors database can be described
through some summary statistics. Table 1 shows the num-
ber of proteins that have been annotated with each of the
main terms for function, and for the type of modification
that is targeted (counted across all functions). Please note
that some proteins can be annotated with more than one
function. The most frequent functions are writing and
reading histone modifications, and chromatin remodeling.
The most frequent targets are not only, in particular,
methylations and acetylations, but also phosphorylations
and ubiquitinations.
Figure 2 shows the most frequent Pfam domains in
EpiFactors. Several of these domains are known to be
strongly associated with epigenetic processes (see later).
Table 2 shows the most significantly enriched Pfam do-
mains. It shows domains that are enriched in EpiFactors
relative to a background of 20 200 reviewed human
UniProt entries (left part of table). It also shows domains
that are enriched for specific functions within EpiFactors,
relative to the whole EpiFactors database (right part of
table). These two tests for enrichment are independent, but
are shown in a joint table because domains that are signifi-
cantly enriched within EpiFactors (e.g. the SET domain)
also tend to be enriched with respect to a specific function
(e.g. writing a histone methylation). All enrichments are
significant at P<0.05 according to a Fisher’s exact test
after Bonferroni correction (not shown), except for
Chromo, PHD and PWWP with respect to Function (right
part).
For each case in Table 2 we show the number of entries
that are inside the set (e.g. in the EpiFactors database) or
outside (e.g. in the reviewed UniProt entries not included
in EpiFactors). The numbers for inclusion in EpiFactors
(left part) show that almost all proteins with the domains
listed here are included. We should stress that this informa-
tion was normally not used when selecting proteins for
EpiFactors, which was based almost exclusively on litera-
ture data. However, the numbers indicate that we have
achieved a good coverage of some important Pfam do-
mains. We see a similar trend for the annotation of
Function within EpiFactors (right part), indicating good
quality of this annotation. The main exceptions are the
Chromo, PHD and PWWP domains, where only subsets of
proteins with these domains are associated with specific
functions.
The domains listed in Table 2 are mainly as expected.
For example, the SET domain is known to be involved in
histone methylation (63), the Jmj (Jumonji) domain in
Table 1. Frequency of main terms in annotation
Function Count Modification Count
DNA modification 22 DNA methylation 7
RNA modification 30 DNA demethylation 12
Chromatin remodeling 101 DNA hydroxymethylation 5
Chromatin remodeling cofactor 41 RNA degradation 9
Histone chaperone 26 mRNA editing 10
Histone modification 15 Histone methylation 127
Histone modification cofactor 12 Histone acetylation 139
Histone modification read 90 Histone phosphorylation 55
Histone modification write 158 Histone ubiquitination 61
Histone modification write cofactor 95 Histone sumoylation 2
Histone modification erase 66 Histone citrullination 4
Histone modification erase cofactor 58 TF activator 18
Polycomb group (PcG) protein 29 TF repressor 27
Scaffold protein 12
TF 53
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histone demethylation (64), the Hist_deacetyl domain in
histone deacetylation and the SNF2 domain in chromatin
remodeling (65).
EpiFactors summary
EpiFactors is a web-accessible database that provides
broad information about human proteins and complexes
involved in epigenetic regulation. It also lists correspond-
ing genes and their expression levels in several samples, in
particular 458 human primary cell samples, 255 different
cancer cell lines and 134 human post-mortem tissues. Each
protein and complex entry has been provided with links to
external public resources. We believe that the database will
be a valuable tool for researchers working in the rapidly
growing field of epigenetics.
Future developments
The database content is carefully maintained and updated.
Repeated literature searches are planned to allow for
Figure 2. The most frequently occurring Pfam domains in EpiFactors. Multiple occurrences of a domain within the same protein are counted as one
occurrence.
Table 2. Significantly enriched Pfam domains
Pfam domain EpiFactors EpiFactors function; modification Function
In Out In Out
SET 36 2 Histone modification write; Histone methylation 33 3
JmjC 22 0 Histone modification erase; Histone methylation 21 1
JmjN 10 0 Histone modification erase; Histone methylation 9 1
Hist_deacetyl 11 0 Histone modification erase; Histone acetylation 11 0
SNF2_N 28 4 Chromatin remodeling 25 3
Bromodomain 36 2 Histone modification 33 3
zf-HC5HC2H_2 12 0 Histone modification; Histone methylation 12 0
Chromo 26 0 Histone modification read 10 16
PHD 55 11 Histone modification read; Histone methylation 17 38
PWWP 16 6 Histone modification read 7 9
In and Out for EpiFactors (left part of table) represents the number of occurrences that are inside and outside the list of EpiFactors (the ‘outside’ set corresponds
to 20 200 reviewed human UniProt entries, minus the EpiFactors entries). In and Out for Function (right part) represents the number of occurrences of the same
Pfam domain that are found inside and outside of that particular term in EpiFactors. All enrichments are statistically significant according to a Fisher’s exact test,
also after correction for multiple testing, except for the Chromo, PHD and PWWP domains with respect to Function (right part).
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identification and integration of new entries into the database
on a regular basis. A module on association of epigenetic fac-
tors with pathological conditions has been planned during
expansion phase. We will also consider inclusion of data for
other model organisms, to broaden the scope of the database
to a larger audience. Any input from groups and individuals
with specific areas of epigenetic expertise is welcome.
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